Literature DB >> 18097187

Protective effect of sildenafil (Viagra) in transient spinal cord ischemia.

Nejmi Kiymaz1, Nebi Yilmaz, Ciğdem Mumcu, Omer Anlar, Süleyman Ozen, Cetin Refik Kayaoğlu.   

Abstract

Prospective study of the neuroprotective activity of sildenafil in a rat spinal ischemia model. The present study involved 21 male Sprague-Dawley rats. The animals were divided into 3 groups. Physiological serum was administered intraperitoneally to the 8 rats in the control group at the beginning of reperfusion for a period of 20 min after abdominal aortal occlusion. Sildenafil (Viagra) was administered as a single 10-mg/kg/day intraperitoneal dose to the 8 rats in the sildenafil group at the beginning of reperfusion after 20 min of abdominal aortal occlusion. No occlusion was performed and no agent was administered to the 5 rats in the sham group, but the abdominal aorta was reached by means of surgical intervention. Before the animals were sacrificed, several physiological and biochemical parameters were investigated, preoperative and postoperative motor functions were also assessed, and somatosensory evoked potential (SEP) monitoring and histopathological examinations were carried out. No differences were found between the physiological and biochemical parameters in each of the 3 groups. Neurological scoring performed after reperfusion demonstrated a significant improvement in the neurological results relative to those of the control group over 48 h in subjects that received sildenafil. These animals also showed better 24-hour SEP results, measured in terms of extended latency and decreased amplitude, than the control animals. A histopathological study showed reduced ischemic symptoms in rats that received sildenafil compared with those in the control group. However, no anomalies were observed in the sham group with respect to the histopathological and neurological findings. These results indicate that neurological damage due to spinal-cord ischemia-reperfusion injury can be reduced by sildenafil. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097187     DOI: 10.1159/000110658

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  4 in total

1.  Neuroprotective effects of sildenafil in experimental spinal cord injury in rabbits.

Authors:  Hasan Kara; Selim Degirmenci; Ahmet Ak; Aysegul Bayir; Seyit Ali Kayis; Mehmet Uyar; Murat Akinci; Demet Acar; Metin Kocacan; Fikret Akyurek
Journal:  Bosn J Basic Med Sci       Date:  2015-01-08       Impact factor: 3.363

2.  PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?

Authors:  Iason Kyriazis; George C Kagadis; Panagiotis Kallidonis; Ioannis Georgiopoulos; Antonia Marazioti; Aikaterini Geronasiou; Despοina Liourdi; George Loudos; Vasilios Schinas; Dimitris Apostolopoulos; Helen Papadaki; Christodoulos Flordellis; George C Nikiforidis; Andreas Papapetropoulos; Evangelos Nu Liatsikos
Journal:  World J Urol       Date:  2012-11-10       Impact factor: 4.226

3.  Sildenafil improves epicenter vascular perfusion but not hindlimb functional recovery after contusive spinal cord injury in mice.

Authors:  Scott A Myers; William H DeVries; Mark J Gruenthal; Kariena R Andres; Theo Hagg; Scott R Whittemore
Journal:  J Neurotrauma       Date:  2011-12-15       Impact factor: 5.269

4.  Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate.

Authors:  L Barros-Miñones; L Orejana; B Goñi-Allo; V Suquía; I Hervías; N Aguirre; E Puerta
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.